Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,599,557

« Back to Dashboard

Summary for Patent: 5,599,557

Title: Stable hydrated cephalosporin dry powder for oral suspension formulation
Abstract:A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
Inventor(s): Johnson; Donald A. (Miami Lakes, FL), Wearley; Lorraine (Westfield, NJ), Galeos; Rebecca (Bloomfield, NJ), Sequeira; Joel A. (New York, NY)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/325,400
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process; Dosage form;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995RXYes5,599,557<disabled>YMETHOD OF TREATING BACTERIAL INFECTIONS
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995RXYes5,599,557<disabled>YTREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995DISCNNo5,599,557<disabled>YTREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
Pernix Therap
CEDAX
ceftibuten dihydrate
FOR SUSPENSION;ORAL050686Dec 20, 1995DISCNNo5,599,557<disabled>YMETHOD OF TREATING BACTERIAL INFECTIONS
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,599,557

PCT Information
PCT FiledApril 30, 1993PCT Application Number:PCT/US93/03856
PCT Publication Date:November 11, 1993PCT Publication Number: WO93/21923

International Patent Family for Patent: 5,599,557

Country Document Number Publication Date
WIPO (PCT)9321923Nov 11, 1993
Slovak Republic131194Jul 11, 1995
Slovak Republic279329Oct 07, 1998
Russia2123863Dec 27, 1998
Poland171630May 30, 1997
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc